Source: Taylor Wessing

Taylor Wessing reports on the United Kingdom’s regulatory approach to artificial intelligence in the life sciences sector, focusing on legal challenges related to data privacy, algorithmic transparency, and compliance with healthcare regulations. The UK aims to implement a balanced regulatory framework that promotes innovation while ensuring patient safety and data protection. Key legal risks include liability for AI-driven medical decisions, ensuring informed consent for AI-based diagnostics, and compliance with the UK General Data Protection Regulation (GDPR).

Legal experts argue that the UK’s strategy could set a precedent for AI regulation in healthcare across Europe, particularly concerning standards for algorithmic transparency and accountability. As AI becomes more integrated into healthcare, addressing these legal challenges will be essential to maintaining trust in AI-driven medical technologies.